Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state

Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice

(2016) H. Vinter et al.   BRITISH JOURNAL OF DERMATOLOGY

Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study

(2016) A. Egeberg et al.   BRITISH JOURNAL OF DERMATOLOGY

IL-10-producing regulatory B cells are decreased in patients with psoriasis

(2016) Mitsuha Hayashi et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine

(2016) C.-H. Kim et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy

(2015) Ankit Saxena et al.   CYTOKINE

A Multihit Model

(2015) Lydia M. Keubler et al.   INFLAMMATORY BOWEL DISEASES

Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?

(2015) Gionata Fiorino et al.   Journal of Crohns & Colitis

The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis

(2015) Nicole C. Rouse et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Toll-like receptor 2 mediates a cutaneous reaction induced by repetitive ultraviolet B irradiation in C57/BL6 micein vivo

(2014) Hyun Sun Park et al.   EXPERIMENTAL DERMATOLOGY

Antidrug antibodies in psoriasis: a systematic review

(2013) L. Hsu et al.   BRITISH JOURNAL OF DERMATOLOGY

TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis

(2013) Barry Flutter et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation

(2013) Koichi Yanaba et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Psoriasis concurrent with inflammatory bowel disease

(2013) H.S. Park et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The need for littermate controls

(2011) Rikard Holmdahl et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Associated comorbidities in psoriasis and inflammatory bowel disease

(2011) A.M. Binus et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis

(2010) Andrea Chiricozzi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Serum cytokines and growth factor levels in Japanese patients with psoriasis

(2009) H. Takahashi et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

(2009) L. van der Fits et al.   JOURNAL OF IMMUNOLOGY

Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis

(2009) Erin G. Harper et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

(2009) Antonella Di Cesare et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis associated with ulcerative colitis and Crohn's disease

(2009) AD Cohen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis

(2009) Frank O. Nestle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease

(2008) Alessandro Borghi et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH